Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-25 Purchase |
2022-11-29 4:11 pm |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
10,000 | $1.43 | $14,300 | 24,481 (Direct) |
View |
| 2021-03-23 Purchase |
2021-03-23 12:24 pm |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
965 | $10.34 | $9,980 | 14,481 (Direct) |
View |
| 2020-05-14 Purchase |
2020-05-18 4:17 pm |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
6,993 | $1.43 | $10,000 | 13,369 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-11 Option Award |
2025-03-13 4:02 pm |
N/A 2035-03-11 |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
758,400 | $0 | 2,925,098 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-07 6:39 pm |
N/A 2034-03-07 |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
510,000 | $0 | 2,170,310 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-16 5:41 pm |
N/A 2033-03-15 |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
482,064 | $0 | 1,664,477 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-10 6:39 pm |
N/A 2032-03-09 |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
370,128 | $0 | 1,185,400 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 4:11 pm |
N/A 2031-06-10 |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
435,072 | $0 | 815,272 (Direct) |
View |
| 2021-01-02 Tax Withholding |
2021-01-05 4:03 pm |
N/A N/A |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
113 | $0 | 13,516 (Direct) |
View |
| 2021-01-02 Exercise |
2021-01-05 4:03 pm |
N/A N/A |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
260 | $0 | 13,516 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:15 pm |
N/A 2030-06-17 |
Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer |
221,241 | $0 | 380,200 (Direct) |
View |